Utilizing techniques such as immunohistochemistry (IHC), immunofluorescence (IF), and flow cytometry for precise quantification of CD33 expression on various cell types. These methods are crucial for understanding the presence and density of CD33 on target cells. IHC and IF provide spatial information on CD33 distribution within tissues.
CD33 Assay Portfolio Service
Introduction What We Can Offer Workflow Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us
Creative Biolabs provides a comprehensive suite of solutions tailored to accelerate your research and development of CD33-targeted therapies. Creative Biolabs delivers precise quantification of CD33 expression, detailed analysis of its functional impact, and crucial insights into its prognostic and therapeutic relevance. Our service is designed to overcome the complexities of CD33 research, from understanding its varied expression patterns to evaluating the efficacy of novel therapeutic candidates.
CD33 as a Target for Cancer Therapy
As a transmembrane glycoprotein, CD33's expression on leukemic blasts and its endocytic properties make it highly attractive for targeted therapies. Research highlights its heterogeneous expression, its role as an unfavorable prognostic marker in AML, and the significance of circulating CD33 (cCD33) levels in predicting patient outcomes and influencing drug efficacy.
Discover how we can help - Request a consultation.
What We Can Offer
CD33 Expression Analysis
Cellular Functional Assays
Our cellular functional assays include cellular uptake, cytotoxicity, cell proliferation, and cell apoptosis assays. These assays study the internalization kinetics of CD33-targeting agents, assess cell killing effects, and evaluate the impact on cell growth and apoptosis.
Ligand Binding Assays
Using assays like ELISA, we perform a quantitative analysis of molecular interactions between CD33 and its binding partners. This service is essential for determining binding affinity, specificity, and kinetics, providing data critical for optimizing drug design and predicting in vivo behavior.
Workflow of CD33 Assay Portfolio Service
Highlights
Unparalleled Expertise & Experience
Our team offers a profound understanding of CD33's complex role, which allows us to anticipate challenges, design nuanced experiments, and provide insightful interpretations of even the most intricate data.
Cutting-Edge Technology & Scientific Rigor
We invest in advanced platforms like high-throughput flow cytometry, SPR/BLI, and NGS, which guarantee unmatched accuracy and reproducibility for your research.
Strategic Partnership Approach
We offer proactive communication and tailored guidance to align our services with your evolving scientific questions and strategic objectives.
Accelerated & Efficient Development
Our pre-validated assays and streamlined workflow are designed to significantly reduce research and development timelines and costs, accelerating the progression of your research.
Experience the Creative Biolabs advantage - Get a quote today.
Customer Reviews
-
Game-Changer for Drug Development
The assays provided by Creative Biolabs were a game-changer for our ADCs development. Understanding the endocytic properties of our CD33-targeting constructs with such accuracy allowed us to optimize drug delivery and significantly enhance in vitro cytotoxicity. - S***h K.
-
Exceptional Precision
Using Creative Biolabs' service in our research has significantly improved the precision of our CD33 expression quantification. Their flow cytometry data is consistently reliable, allowing us to confidently stratify samples. - Prof. A***a M.
FAQs
What types of samples can I submit for CD33 expression analysis?
We accept a wide range of biological samples, including peripheral blood, isolated primary cells, and various CD33-expressing or control cell lines. These diverse sample types allow us to accommodate various research needs, from early-stage target validation to more advanced preclinical studies involving patient-derived materials.
Can your functional assays help me evaluate the efficacy of my CD33-targeting antibody-drug conjugate?
Absolutely! Our comprehensive portfolio includes specialized functional assays meticulously designed to evaluate the efficacy and mechanism of action of CD33-targeting ADCs. Cellular uptake assays are paramount for understanding the internalization kinetics of your ADCs, a crucial step for payload delivery. Cytotoxicity assays directly measure the ADCs' ability to induce cell killing in CD33-positive cells.
Related Services
ADCs Technology
Comprehensive support for the design, synthesis, and characterization of novel ADCs. This includes expert guidance on antibody selection, payload identification, and the optimization of linker chemistry to ensure stability and targeted release.
Learn More →Cell Line Development Service
This encompasses designing and constructing cell lines with specific gene knock-ins, knock-outs, or reporter constructs, essential for establishing robust in vitro models that accurately reflect disease biology and drug response.
Learn More →Biomarker Development Service
Leveraging advanced proteomics, genomics, and bioinformatics platforms, we delve into the molecular mechanisms of disease, helping you pinpoint the most promising targets and identify predictive or prognostic biomarkers.
Learn More →How to Contact Us
Creative Biolabs' CD33 assay portfolio service is your gateway to deeper insights and accelerated development in the fight against myeloid malignancies and other CD33-related conditions. Our integrated approach, combining cellular and circulating CD33 analysis with comprehensive functional and genetic profiling, empowers you to make data-driven decisions and advance your therapeutic candidates with confidence.
Contact us for more information and to discuss your project.
Download our brochureLoading case studies...
Online Inquiry